2013 annual financial data
ImmunityBio 2013 Net margin
ImmunityBio 2013 net margin with verified reported values.
Direct answer
Net margin was -341.17%.
Operating income was -2,269,000 USD and net income was -2,047,000 USD.
Operating cash flow was -668,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 600,000 USD
- Operating income
- -2,269,000 USD
- Net income
- -2,047,000 USD
- Operating cash flow
- -668,000 USD